ARCHIVES

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

CMS Advisors Express Low Confidence In Low-Dose CT Screening for Lung Cancer

May 9, 2014

Acupuncture Can Relieve Side Effects of Hormone Treatment

April 29, 2011

FDA Proposes Office For Patients With Life Threatening Disease

November 13, 1992

September issue of Business & Regulatory Report included–8 additional pages of industry news.

October 1, 2004

CMS To Begin National Coverage Analysis Of Provenge

July 2, 2010

In Brief: XIIIth Congress Draws Record Number Of Abstracts, 3,000 Registrants So Far; Exhibit Area Sold Out

March 5, 1982